These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
635 related articles for article (PubMed ID: 28336292)
1. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Chiang N; Serhan CN Mol Aspects Med; 2017 Dec; 58():114-129. PubMed ID: 28336292 [TBL] [Abstract][Full Text] [Related]
2. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. Serhan CN FASEB J; 2017 Apr; 31(4):1273-1288. PubMed ID: 28087575 [TBL] [Abstract][Full Text] [Related]
3. Specialized pro-resolving mediator network: an update on production and actions. Chiang N; Serhan CN Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825 [TBL] [Abstract][Full Text] [Related]
4. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition. Serhan CN; Libreros S; Nshimiyimana R Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568 [TBL] [Abstract][Full Text] [Related]
5. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders. Han YH; Lee K; Saha A; Han J; Choi H; Noh M; Lee YH; Lee MO Biomol Ther (Seoul); 2021 Sep; 29(5):455-464. PubMed ID: 34162770 [TBL] [Abstract][Full Text] [Related]
7. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation. Serhan CN; de la Rosa X; Jouvene C J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762 [TBL] [Abstract][Full Text] [Related]
13. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators. Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803 [TBL] [Abstract][Full Text] [Related]
14. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Bannenberg G; Serhan CN Biochim Biophys Acta; 2010 Dec; 1801(12):1260-73. PubMed ID: 20708099 [TBL] [Abstract][Full Text] [Related]
15. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. Recchiuti A; Serhan CN Front Immunol; 2012; 3():298. PubMed ID: 23093949 [TBL] [Abstract][Full Text] [Related]
16. Developments of specialized pro-resolving mediators in periodontitis. Liu YC Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):94-98. PubMed ID: 33723943 [TBL] [Abstract][Full Text] [Related]
17. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Serhan CN Am J Pathol; 2010 Oct; 177(4):1576-91. PubMed ID: 20813960 [TBL] [Abstract][Full Text] [Related]
18. Resolution of inflammation in oral diseases. Eltay EG; Van Dyke T Pharmacol Ther; 2023 Jul; 247():108453. PubMed ID: 37244405 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory and proresolving lipid mediators. Serhan CN; Yacoubian S; Yang R Annu Rev Pathol; 2008; 3():279-312. PubMed ID: 18233953 [TBL] [Abstract][Full Text] [Related]
20. Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease. Spite M Proc Nutr Soc; 2013 Nov; 72(4):441-50. PubMed ID: 23991833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]